News Pharmaspectra appoints UDG’s Jez Moulding as CEO Jez Moulding has moved from UDG and its Ashfield business to join and lead medical science information company Pharmaspectra.
News Teva makes its first M&A play in years, buying Emalex Teva has made its first pipeline-building acquisition in almost a decade, buying Tourette syndrome drug developer Emalex for up to $900m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
